SEC Form 4
InspireMD, Inc. (NSPR) insider trading
In the 12 months to Oct 26, 2026, 4 NSPR insiders reported open-market purchases of $420.8K across 11 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $420.8K
- 11 filings
Who traded NSPR, and when
- Purchase
NSPR daily close from Oct 27, 2025 to Oct 26, 2026, between $0.44 and $2.29, last $0.44. 0 sale and 11 purchase filings by 4 insiders, marked at their filing dates. Paul Stuka, Director: bought $186.7K across 8 filings, first filed Nov 13, 2025, last May 29, 2026. Gary S. Roubin, Director: bought $106.2K across 1 filing, first filed May 8, 2026, last May 8, 2026. Scott R. Ward, Director: bought $102.6K across 1 filing, first filed May 8, 2026, last May 8, 2026. Marvin Slosman, CEO and President: bought $25.2K across 1 filing, first filed May 13, 2026, last May 13, 2026.
Largest mark · tap a row for others
Gary S. Roubin · Director
Purchase $106,200
90,000 shares at $1.18 avg
Filed May 8, 2026 · traded May 7
Close on filing date $1.15
Paul Stuka · Director
Director
$186.7K boughtGary S. Roubin · Director
Director
$106.2K boughtScott R. Ward · Director
Director
$102.6K boughtMarvin Slosman · CEO and President
CEO and President
$25.2K boughtOpen-market trades
11 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Paul Stuka | Director | — | $186.7K | 8 | — | |
| Gary S. Roubin | Director | — | $106.2K | 1 | — | |
| Scott R. Ward | Director | — | $102.6K | 1 | — | |
| Marvin Slosman | CEO and President | — | $25.2K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Paul Stuka Director | Purchase | 20,000 | $0.88 | $17.5K | 667,871 | |
traded | Paul Stuka Director | Purchase | 15,000 | $1.16 | $17.3K | 647,871 | |
traded | Paul Stuka Director | Purchase | 75,626 | $1.16 | $88.0K | 632,871 | |
traded | Marvin Slosman CEO and President | Purchase | 21,000 | $1.20 | $25.2K | 3,556,658 | |
traded | Gary S. Roubin Director | Purchase | 90,000 | $1.18 | $106.2K | 834,478 | |
traded | Paul Stuka Director | Purchase | 7,895 | $1.14 | $9.0K | 531,599 | |
traded | Scott R. Ward Director | Purchase | 89,250 | $1.15 | $102.6K | 237,096 | |
traded | Paul Stuka Director | Purchase | 2,710 | $1.81 | $4.9K | 391,628 | |
traded | Paul Stuka Director | Purchase | 5,073 | $1.86 | $9.4K | 388,918 | |
traded | Paul Stuka Director | Purchase | 10,130 | $1.85 | $18.7K | 383,845 | |
traded | Paul Stuka Director | Purchase | 13,431 | $1.62 | $21.8K | 373,715 |
GET /stocks/filings/vX/form-4?tickers=NSPR&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"NSPR"
],
"issuer_cik": "0001433607",
"owner_cik": "0001528577",
"accession_number": "0001493152-26-026348",
"form_type": "4",
"filing_date": "2026-05-29",
"period_of_report": "2026-05-27",
"issuer_name": "InspireMD, Inc.",
"issuer_trading_symbol": "NSPR",
"owner_name": "Stuka Paul",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-05-27",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 20000,
"transaction_price_per_share": 0.875,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 667871,
"transaction_value": 17500,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $0.87 to $0.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."
}
]
},
{
"tickers": [
"NSPR"
],
"issuer_cik": "0001433607",
"owner_cik": "0001528577",
"accession_number": "0001493152-26-023727",
"form_type": "4",
"filing_date": "2026-05-15",
"period_of_report": "2026-05-13",
"issuer_name": "InspireMD, Inc.",
"issuer_trading_symbol": "NSPR",
"owner_name": "Stuka Paul",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-05-13",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 1.1575,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 642871,
"transaction_value": 11575,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.1550 to $1.1599. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 35 records
- Tax withholding (sold to cover)24 records
- Grants and awards11 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has InspireMD, Inc.'s CEO sold stock?
No. Marvin Slosman (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is NSPR’s insider data?
These are NSPR Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track NSPR insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for NSPR every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.